July 31, 2025

Medical Oddities: Bubble Tea May Brew Burnout

From bubble tea to AI triage, small inputs had big impacts on mood, and memory.

Conexiant

August 05, 2025

Weight Regain Persists After Anti-Obesity Treatment

A new meta-analysis of 11 randomized controlled trials found that patients began regaining weight as early as 8 weeks after discontinuing anti-obesity medications, with weight gain continuing through 52 weeks.

Conexiant

July 09, 2025

What Makes People 'Cool?' Research from the Journal of Experimental Psychology

Despite differing norms and values across societies, six characteristics show remarkable consistency in defining "coolness" worldwide. 

Conexiant

August 04, 2025

Nitazenes: A Hidden Threat Stronger Than Fentanyl

The drug can be hundreds of times stronger than heroin and up to five times more potent than fentanyl.

Conexiant

August 01, 2025

Physicians Urged to Defend USPSTF Role

The Colorectal Cancer Alliance and partners are urging the Department of Health and Human Services to preserve U.S. Preventive Services Task Force’s evidence-based role in safeguarding access to no-cost colorectal cancer screening.

Conexiant

July 22, 2025

Placenta Accreta Guidelines Lack Consensus: Review

A new review of clinical guidelines highlights consistent recommendations for diagnosing and managing placenta accreta spectrum disorders, but showed gaps in guidance for surgery, fertility counseling, and postnatal care, especially in low-resource settings.

Conexiant

July 21, 2025

Preeclampsia Risk Scores Under USPSTF Lack Precision, Study Finds

Researchers found that USPSTF guidelines inadequately stratify preeclampsia risk among pregnant patients, particularly those at moderate risk, and therefore limit the utility of aspirin prophylaxis recommendations.

Conexiant

July 17, 2025

Hormone Therapy Type Tied to Diverging Risks of Breast Cancer Before Age 55

Researchers found that unopposed estrogen therapy was linked to reduced young-onset breast cancer risk, while estrogen plus progestin therapy increased risk in certain subgroups.

Conexiant

July 17, 2025

FDA Approves Shingrix Prefilled Syringe Option

The FDA has approved a new prefilled syringe presentation of Shingrix to simplify herpes zoster vaccination for eligible adult patients.

Conexiant